• inquiry@market.us
  • +1 718 618 4351 (International)
  • +91 78878 22626 (Asia)
  • About Us
  • Contact Us
menu One Stop Shop For Reports One Stop Shop For Reports
search more_vert
  • All Reports
  • All Sectors
  • Infographics
  • News Media
    • United States
    • United Kingdom
    • Asia Pacific
  • Who Trust Us
  • Datafeature
Home / Anti-Streptolysin Reagents Market
  • Home / Anti-Streptolysin Reagents Market

Global Anti-Streptolysin Reagents Market By Analysis (Qualitative, Semi-Quantitative, Quantitative), By End-User (Hospitals, Research Laboratories, Diagnostic Laboratories, Academic & Research Institutes), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2021-2031

  • Overview
  • Table of Contents
  • Major Market Players
  • Inquiry Before Buying
  • account_circleAbout Me
    • 74551
    • US $6,000
      US $3,999
    • US $8,000
      US $5,999
    • US $10,000
      US $6,999
    Buy Now

    Streptolysin is a hemolytic exotoxin generated by Streptococcaceae bacteria. Streptolysin O (SLO) and Streptolysin S (SLS) are two forms of streptomycin, with SLO being more hemolytically active than SLS due to its larger size.

    To measure the quantities of antibodies generated against SLO, anti-streptolysin reagents, kits, assays, and titers are used. Anti-streptolysin reagents are used to titrate anti-streptolysin reagents with a patient's serum sample to assess the toxicity and levels of SLO.

    Acute rheumatic fever or acute post-streptococcal glomerulonephritis can be caused by infections, which can be diagnosed using anti-streptolysin reagents. To check for toxins, anti-streptolysin reagents, as well as appropriate calibrators and controls are commonly available in kits from various vendors.

    Request Covid - 19 Impact

    Anti-streptolysin reagents provide valuable information for infection diagnosis and monitoring. Scarlet fever, tonsillitis, otitis, and erysipelas are among the illnesses that can be detected. The market for anti-streptolysin reagents is expected to increase as people become more aware of the signs and symptoms caused by antibodies produced.

    Detailed Segmentation –

    Analysis Type:

    • Qualitative
    • Semi-Quantitative
    • Quantitative

    End-User:

    • Hospitals
    • Research Laboratories
    • Diagnostic Laboratories
    • Academic & Research Institutes

    Based on Region:

    • North America
    • Europe
    • Asia-Pacific
    • South America
    • Middle East & Africa

    Market Dynamics –

    Driver for the Global Anti-Streptolysin Reagents Market:

    The increasing availability of anti-streptolysin reagent kits over-the-counter is expected to lead to greater revenues, thereby boosting the anti-streptolysin reagents market in the process. Owing to the surging frequency of otitis and tonsillitis among youngsters, the anti-streptolysin reagents market is expected to augment gradually in years to come.

    Restraints Global Anti-Streptolysin Reagents Market:

    Opportunities for the Global Anti-Streptolysin Reagents Market:

    Anti-streptolysin reagents are expected to be in high demand from research and academic institutes for educational purposes, creating a stable demand for anti-streptolysin reagents. Hemolysis caused by infections in post-surgical operations is also expected to lead to further expansion potential for the anti-streptolysin reagents market.

    Trends for the Global Anti-Streptolysin Reagents Market:

    Acute pharyngitis, one of the most prevalent infections of the throat, and its increasing prevalence across the globe is expected to aid in boosting the revenue growth trajectory of the anti-streptolysin reagents market. As more contract research & development organizations focus on understanding the efficacy and cytotoxicity of reactions, the potential for  the anti-streptolysin reagents market to subsequently grow is increase.

    Competitive Landscape –

    • Biosystems S.A.
    • Randox Laboratories Ltd.
    • Kamiya Biomedical Company
    • ELITechGroup
    • Erba Lachema S.R.O.
    • Lab Care Diagnostics (India) Pvt. Ltd.
    • Adaltis S.r.l.
    • Lorne Laboratories Limited
    • DiaSys Diagnostic Systems GmbH
    • Diagnostic Automation/Cortez Diagnostics Inc.

    For the Anti-Streptolysin Reagents Market research study, the following years have been considered to estimate the market size:

    Particular Scope
    Region

    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa
    Historic Year 2016 to 2020
    Base Year 2021
    Estimated Year 2022
    Forecast Year 2023 to 2032

    Anti-Streptolysin Reagents Market

    add_shopping_cartBuy Now get_appDownload Sample
    keyboard_arrow_up
  • account_circleAbout Me
    • 74551
    • US $6,000
      US $3,999
    • US $8,000
      US $5,999
    • US $10,000
      US $6,999
    Buy Now
    • 1.Anti-Streptolysin Reagents Market Introduction
      • 1.1.Definition
      • 1.2.Taxonomy
      • 1.3.Research Scope
    • 2.Executive Summary
      • 2.1.Key Findings by Major Segments
      • 2.2.Top strategies by Major Players
    • 3.Global Anti-Streptolysin Reagents Market Overview
      • 3.1.Anti-Streptolysin Reagents Market Dynamics
        • 3.1.1.Drivers
        • 3.1.2.Opportunities
        • 3.1.3.Restraints
        • 3.1.4.Challenges
      • 3.2.COVID-19 Impact Analysis
      • 3.3.COVID-19 Impact Analysis in Global Anti-Streptolysin Reagents Market
      • 3.4.PESTLE Analysis
      • 3.5.Opportunity Map Analysis
      • 3.6.PORTER'S Five Forces Analysis
      • 3.7.Market Competition Scenario Analysis
      • 3.8.Product Life Cycle Analysis
      • 3.9.Opportunity Orbits
      • 3.10.Manufacturer Intensity Map
      • 3.11.Major Companies sales by Value & Volume
    • 4.Global Anti-Streptolysin Reagents Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Analysis Type, 2016-2032
      • 4.1.Global Anti-Streptolysin Reagents Market Analysis by Analysis Type: Introduction
      • 4.2.Market Size and Forecast by Region
      • 4.3.Qualitative
      • 4.4.Semi-Quantitative
      • 4.5.Quantitative
    • 5.Global Anti-Streptolysin Reagents Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by End-User, 2016-2032
      • 5.1.Global Anti-Streptolysin Reagents Market Analysis by End-User: Introduction
      • 5.2.Market Size and Forecast by Region
      • 5.3.Hospitals
      • 5.4.Research Laboratories
      • 5.5.Diagnostic Laboratories
      • 5.6.Academic & Research Institutes
    • 6.Global Anti-Streptolysin Reagents Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Region, 2016-2032
      • 6.1.North America
        • 6.1.1.North America Anti-Streptolysin Reagents Market: Regional Trend Analysis
          • 6.1.1.1.U.S.
          • 6.1.1.2.Canada
          • 6.1.1.3.Mexico
      • 6.2.1.Europe
        • 6.2.1.Europe Anti-Streptolysin Reagents Market: Regional Trend Analysis
          • 6.2.1.1.U.K.
          • 6.2.1.2.Germany
          • 6.2.1.3.France
          • 6.2.1.4.Spain
          • 6.2.1.5.Italy
          • 6.2.1.6.Russia
          • 6.2.1.7.Rest of Europe
      • 6.3.Asia-Pacific
        • 6.3.1.Asia-Pacific Anti-Streptolysin Reagents Market: Regional Trend Analysis
          • 6.3.1.1.China
          • 6.3.1.2.Japan
          • 6.3.1.3.South Korea
          • 6.3.1.4.India
          • 6.3.1.5.ASEAN
          • 6.3.1.6.Rest of Asia-Pacific
      • 6.4.Latin America
        • 6.4.1.Latin America Anti-Streptolysin Reagents Market: Regional Trend Analysis
          • 6.4.1.1.Brazil
          • 6.4.1.2.Argentina
          • 6.4.1.3.Rest of Latin America
      • 6.5.Middle East and Africa
        • 6.5.1.Middle East and Africa Anti-Streptolysin Reagents Market: Regional Trend Analysis
          • 6.5.1.1.GCC
          • 6.5.1.2.Israel
          • 6.5.1.3.South Africa
          • 6.5.1.4.Rest of MEA
    • 7.Global Anti-Streptolysin Reagents Market Competitive Landscape, Market Share Analysis, and Company Profiles
      • 7.1.Market Share Analysis
      • 7.2.Company Profiles
      • 7.3.Biosystems S.A.
        • 7.3.1.Company Overview
        • 7.3.2.Financial Highlights
        • 7.3.3.Product Portfolio
        • 7.3.4.SWOT Analysis
        • 7.3.5.Key Strategies and Developments
      • 7.4.Randox Laboratories Ltd.
        • 7.4.1.Company Overview
        • 7.4.2.Financial Highlights
        • 7.4.3.Product Portfolio
        • 7.4.4.SWOT Analysis
        • 7.4.5.Key Strategies and Developments
      • 7.5.Kamiya Biomedical Company
        • 7.5.1.Company Overview
        • 7.5.2.Financial Highlights
        • 7.5.3.Product Portfolio
        • 7.5.4.SWOT Analysis
        • 7.5.5.Key Strategies and Developments
      • 7.6.ELITechGroup
        • 7.6.1.Company Overview
        • 7.6.2.Financial Highlights
        • 7.6.3.Product Portfolio
        • 7.6.4.SWOT Analysis
        • 7.6.5.Key Strategies and Developments
      • 7.7.Erba Lachema S.R.O.
        • 7.7.1.Company Overview
        • 7.7.2.Financial Highlights
        • 7.7.3.Product Portfolio
        • 7.7.4.SWOT Analysis
        • 7.7.5.Key Strategies and Developments
      • 7.8.Lab Care Diagnostics (India) Pvt. Ltd.
        • 7.8.1.Company Overview
        • 7.8.2.Financial Highlights
        • 7.8.3.Product Portfolio
        • 7.8.4.SWOT Analysis
        • 7.8.5.Key Strategies and Developments
      • 7.9.Adaltis S.r.l.
        • 7.9.1.Company Overview
        • 7.9.2.Financial Highlights
        • 7.9.3.Product Portfolio
        • 7.9.4.SWOT Analysis
        • 7.9.5.Key Strategies and Developments
      • 7.10.Lorne Laboratories Limited
        • 7.10.1.Company Overview
        • 7.10.2.Financial Highlights
        • 7.10.3.Product Portfolio
        • 7.10.4.SWOT Analysis
        • 7.10.5.Key Strategies and Developments
      • 7.11.DiaSys Diagnostic Systems GmbH
        • 7.11.1.Company Overview
        • 7.11.2.Financial Highlights
        • 7.11.3.Product Portfolio
        • 7.11.4.SWOT Analysis
        • 7.11.5.Key Strategies and Developments
      • 7.12.Diagnostic Automation/Cortez Diagnostics Inc.
        • 7.12.1.Company Overview
        • 7.12.2.Financial Highlights
        • 7.12.3.Product Portfolio
        • 7.12.4.SWOT Analysis
        • 7.12.5.Key Strategies and Developments
    • 8.Assumptions and Acronyms
    • 9.Research Methodology
    • 10.Contact
  • ondemand_videoVideos
    • 74551
    • US $6,000
      US $3,999
    • US $8,000
      US $5,999
    • US $10,000
      US $6,999
    Buy Now
    • Biosystems S.A.
    • Randox Laboratories Ltd.
    • Kamiya Biomedical Company
    • ELITechGroup
    • Erba Lachema S.R.O.
    • Lab Care Diagnostics (India) Pvt. Ltd.
    • Adaltis S.r.l.
    • Lorne Laboratories Limited
    • DiaSys Diagnostic Systems GmbH
    • Diagnostic Automation/Cortez Diagnostics Inc.
  • settingsSettings

Our Clients

Request for Sample


  • 74551
  • US $6,000
    US $3,999
  • US $8,000
    US $5,999
  • US $10,000
    US $6,999
Buy Now
  • location_on420 Lexington Avenue, Suite 300 New York City, NY 10170,
    United States
  • phone+1 718 618 4351 (International)
  • phone+91 78878 22626 (Asia)
  • emailinquiry@market.us

Find Help

  • Contact Us
  • How to Order

Legal

  • Privacy Policy
  • Refund Policy
  • Frequently Asked Questions
  • Terms and Conditions

Explore

  • About Us
  • All Reports
  • All Sectors
  • Infographics
  • Statistics and Facts

Secured Payment Options

© 2022 Market.Us. All Rights Reserved.